Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts

Canadian Journal of Anesthesia

Volumn 50, Issue 5, 2003, Pages 489-494

  Kurosawa, Saori ^a   Kanaya, Noriaki ^a   Niiyama, Yukitoshi ^a   Nakayama, Masayasu ^a   Fujita, Satoshi ^a   Namiki, Akiyoshi ^a  

^a Sapporo University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; HEPARIN; KETAMINE; LANDIOLOL; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SPECIFICITY; GUINEA PIG; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0038642733     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03021062     Document Type: Article

References (23)

1. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting β-blocker, ONO -1101. Chem Pharm Bull 1992; 40: 1462-9.
2. Muraki K, Nakagawa H, Nagano N, et al. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther 1996; 278: 555-63.
3. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth 2001; 48: 985-9.
4. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992; 19: 1622-33.
5. Anonymous. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2: 57-66.
6. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17.
7. Mehlhorn U. Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. Thorac Cardiovasc Surg 1997; 45: 224-31.
8. Yasuda T, Kamiya H, Tanaka Y, Watanabe G. Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur J Cardiothorac Surg 2001; 19: 647-52.
9. Gross GJ, Buch JD, Warltier DC, Hardman HF. Role of autoregulation in the beneficial action of propranolol on ischemic blood flow distribution and stenosis severity in the canine myocardium. J Pharmacol Exp Ther 1982; 222: 635-40.
10. Mak IT, Wglicki WB. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988; 63: 262-6.
11. Roth E, Torok B. Effect of the ultrashort-acting β-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res Cardiol 1991; 86: 422-33.
12. Roth E, Matos G, Guarnieri C, Papp B, Varga J. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow. Acta Physiol Hung 1995; 83: 163-70.
13. Takeo S, Yamada H, Tanonaka K, Hayashi M, Sunagawa N. Possible involvement of membrane-stabilizing action in beneficial effect of beta adrenoceptor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther 1990; 254: 847-56.
14. Temsah RM, Dyck C, Netticadan T, Chapman D, Elimban V, Dhalla NS. Effect of β-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J Pharmacol Exp Ther 2000; 293: 15-23.
15. 2+ sensitivity during hypothermia in isolated guinea pig beating hearts. Anesth Analg 2001; 93: 846-52.
16. Ichihara K, Abiko Y. Effects of diltiazem and propranolol on irreversibility of ischemic cardiac function and metabolism in the isolated perfused rat heart. J Cardiovasc Pharmacol 1983; 5: 745-51.
17. Strasser RH, Marquetant R, Kübler W. Adrenergic receptors and sensitization of adenylyl cyclase in acute myocardial ischemia. Circulation 1990; 82(Suppl II): II23-9.
18. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 1990; 52: 543-59.
19. 2+ transport due to excess catecholamines. Cardiovasc Drugs Ther 1996; 10: 231-8.
20. Khaper N, Rigatto C, Seneviratne C, Li T, Singal PK. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 1997; 29: 3335-44.
21. Sakurada A, Voss DO, Brandao D, Campello AP. Effects of propranolol on heart muscle mitochondria. Biochem Pharmacol 1972; 21: 535-40.
22. Liu X, Engelman RM, Agrawal HR, Das DK. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol 1991; 23: 1091-100.
23. Nishina K, Akamatsu, H, Mikawa K, Shiga M, Obara H, Niwa Y. A comparison of atenolol, labetalol, esmolol, and landiolol for altering human neutrophil functions. Anesth Analg 2001; 93: 641-4.